AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness

AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness

By Excelsio Media on September 09, 2020 Also in coronavirus, covid-19, vaccine

AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)